Cargando…
Photobiomodulation in Alzheimer’s Disease—A Complementary Method to State-of-the-Art Pharmaceutical Formulations and Nanomedicine?
Alzheimer’s disease (AD), as a neurodegenerative disorder, usually develops slowly but gradually worsens. It accounts for approximately 70% of dementia cases worldwide, and is recognized by WHO as a public health priority. Being a multifactorial disease, the origins of AD are not satisfactorily unde...
Autores principales: | Ailioaie, Laura Marinela, Ailioaie, Constantin, Litscher, Gerhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054386/ https://www.ncbi.nlm.nih.gov/pubmed/36986776 http://dx.doi.org/10.3390/pharmaceutics15030916 |
Ejemplares similares
-
Synergistic Nanomedicine: Photodynamic, Photothermal and Photoimmune Therapy in Hepatocellular Carcinoma: Fulfilling the Myth of Prometheus?
por: Ailioaie, Laura Marinela, et al.
Publicado: (2023) -
Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges
por: Ailioaie, Laura Marinela, et al.
Publicado: (2021) -
Photobiomodulation and Sports: Results of a Narrative Review
por: Ailioaie, Laura Marinela, et al.
Publicado: (2021) -
Curcumin and Photobiomodulation in Chronic Viral Hepatitis and Hepatocellular Carcinoma
por: Ailioaie, Laura Marinela, et al.
Publicado: (2020) -
Molecular and Cellular Mechanisms of Arthritis in Children and Adults: New Perspectives on Applied Photobiomodulation
por: Ailioaie, Laura Marinela, et al.
Publicado: (2020)